These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7425398)

  • 1. Terbutaline in the treatment of chronic urticaria.
    Spangler DL; Vanderpool GE; Carroll MS; Tinkelman DG
    Ann Allergy; 1980 Oct; 45(4):246-7. PubMed ID: 7425398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study.
    Laurberg G
    Acta Derm Venereol; 1977; 57(4):369-70. PubMed ID: 70935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
    Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
    Kalimo K; Jansen CT
    Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of four antihistamines in chronic urticaria.
    Youngchaiyud U
    J Med Assoc Thai; 1988 Oct; 71(10):548-52. PubMed ID: 2907911
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketotifen and terbutaline in urticaria.
    Saihan EM
    Br J Dermatol; 1981 Feb; 104(2):205-6. PubMed ID: 7213553
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
    Giménez-Arnau A; Izquierdo I; Maurer M
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1088-91. PubMed ID: 19453774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
    Gimenez-Arnau A; Pujol RM; Ianosi S; Kaszuba A; Malbran A; Poop G; Donado E; Perez I; Izquierdo I; Arnaiz E;
    Allergy; 2007 May; 62(5):539-46. PubMed ID: 17441794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
    Lambert D; Hantzperg M; Danglas P; Bloom M
    Allerg Immunol (Paris); 1993 Jun; 25(6):235-40. PubMed ID: 8357472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
    Vena GA; Cassano N; Colombo D; Peruzzi E; Pigatto P;
    J Am Acad Dermatol; 2006 Oct; 55(4):705-9. PubMed ID: 17010756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect in man of oral terbutaline on cutaneous reactions induced by allergen and cold stimulation.
    Grönneberg R; Hägermark O; Strandberg K
    Allergy; 1980 Mar; 35(2):143-7. PubMed ID: 6992626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
    Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
    Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A; Pichler WJ
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial.
    Vena GA; Cassano N; D'Argento V; Milani M
    Br J Dermatol; 2006 Feb; 154(2):353-6. PubMed ID: 16433809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium cromoglycate and provocation tests in chronic urticaria.
    Ortolani C; Cornelli U; Bellani M; Pastorello E; Zanussi C
    Ann Allergy; 1982 Jan; 48(1):50-2. PubMed ID: 6798902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of treatment with loratadine in patients with chronic urticaria].
    Siergiejko Z; Chyrek-Borowska S
    Pol Tyg Lek; 1994 Apr 4-11; 49(14-15):334-6. PubMed ID: 7854994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ketotifen treatment of chronic urticaria. An open study of therapeutically difficult courses].
    Taube KM; Wozniak KD; Lässig W
    Z Hautkr; 1985 Dec; 60(23):1878, 1881-2, 1885. PubMed ID: 4090577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.